ISSN 1006-298X      CN 32-1425/R

导航

肾脏病与透析肾移植杂志 ›› 2026, Vol. 35 ›› Issue (3): 270-275.DOI: 10.3969/j.issn.1006-298X.2026.03.014

• 肾脏病基础 • 上一篇    下一篇

乳酸化修饰在糖尿病肾病中的作用机制和临床前景

  

  • 出版日期:2026-06-29 发布日期:2026-07-02

The mechanism and clinical prospects of lactylation in diabetic kidney disease

  • Online:2026-06-29 Published:2026-07-02

摘要: 糖尿病肾病 (DKD) 是糖尿病最严重的微血管并发症之一,为全球终末期肾病的主要原因。其病理机制复杂,传统的治疗手段难以有效遏制肾功能衰竭的进展。乳酸化修饰 (Kla) 作为新型蛋白质翻译后修饰,广泛参与代谢性疾病的发生发展,其通过乳酸代谢异常驱动的赖氨酸残基酰化修饰调控蛋白质功能,在 DKD 的发生发展中发挥关键调控作用。本文系统总结 DKD 代谢重编程驱动乳酸堆积的分子机制、Kla 相关受体及酶促调控的核心激活路径,阐述组蛋白与非组蛋白乳酰化介导肾损伤的作用机制,并探讨 Kla 在 DKD 中潜在的治疗靶点及临床转化前景,为 DKD 的诊疗提供新的理论依据和研究方向。

关键词: 乳酸化修饰, 糖尿病肾病, 乳酸代谢, 代谢重编程, 肾脏纤维化

Abstract: Diabetic kidney disease (DKD) is one of the most severe microvascular complications of diabetes mellitus and a leading cause of end-stage renal disease worldwide. Due to the complex pathological mechanisms, conventional therapies are unable to effectively arrest the progression of renal failure. A novel post-translational protein modification lactylation (Kla), is widely involved in the pathogenesis and progression of metabolic diseases. It modulates protein function via lysine residue lactylation triggered by abnormal lactate metabolism, and exerts a critical regulatory role in the initiation and progression of DKD. This review systematically summarizes the molecular mechanisms of lactate accumulation induced by metabolic reprogramming in DKD, as well as the core activation pathways of Kla related to receptors and enzymatic regulation. It elaborates the mechanisms of renal injury mediated by histone and non-histone lactylation, and discusses the potential therapeutic targets and clinical translation prospects of Kla in DKD, so as to provide new theoretical basis and research directions for the diagnosis and treatment of DKD.

Key words: lactylation, diabetic kidney disease, lactic acid metabolism, metabolic reprogramming, renal fibrosis

中图分类号: